Eledon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Selling, General & Admin	12.69	12.7	13.13	10.05	6.06	7.24	11.1	1.94	12.62	8.89	Upgrade
Research & Development	30.31	27.08	23.74	6.13	8.13	6.82	2.02	3.19	32.64	14.58	Upgrade
Other Operating Expenses	0	48.65	0	2.28	1.87	0	0	0	0	0	Upgrade
Operating Expenses	43	88.43	36.87	18.47	16.05	14.06	13.12	5.13	45.26	23.46	Upgrade
Operating Income	-43	-88.43	-36.87	-18.47	-16.05	-14.06	-13.12	-5.13	-45.26	-23.46	Upgrade
Other Expense / Income	-2.67	-0.46	-0.01	4.75	-0.04	0.01	-0.01	0.53	-0.17	-0.17	Upgrade
Pretax Income	-40.33	-87.97	-36.86	-23.22	-16.01	-14.07	-13.12	-5.66	-45.09	-23.3	Upgrade
Income Tax	0	0	-2.35	-0.4	0	0	0	0	0	0	Upgrade
Net Income	-40.33	-87.97	-34.51	-22.81	-16.01	-14.07	-13.12	-5.66	-45.09	-23.3	Upgrade
Shares Outstanding (Basic)	25	14	15	1	1	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	25	14	15	1	1	1	0	0	0	0	Upgrade
Shares Change	72.34%	-3.61%	921.03%	121.41%	31.03%	92.52%	1122.10%	-84.68%	247.55%	1455.06%	Upgrade
EPS (Basic)	-1.64	-6.16	-2.33	-15.72	-24.42	-28.08	-41.40	-44.28	-325.62	-583.20	Upgrade
EPS (Diluted)	-1.64	-6.16	-2.33	-15.72	-24.42	-28.08	-41.40	-44.28	-325.62	-583.20	Upgrade
Free Cash Flow	-39.53	-28.42	-28.91	-15.21	-13.86	-11.89	-14.93	-4.92	-41.8	-21.15	Upgrade
Free Cash Flow Per Share	-1.61	-1.99	-1.95	-10.48	-21.14	-23.77	-57.46	-231.47	-301.18	-529.53	Upgrade
EBITDA	-39.95	-87.59	-36.67	-23.03	-15.83	-14.05	-13.09	-5.62	-44.98	-23.28	Upgrade
Depreciation & Amortization	0.37	0.37	0.2	0.18	0.18	0.01	0.02	0.04	0.11	0.02	Upgrade
EBIT	-40.33	-87.97	-36.86	-23.22	-16.01	-14.07	-13.12	-5.66	-45.09	-23.3	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).